Cetera Advisor Networks’s Rocket Pharmaceuticals RCKT Stock Holding History

Cetera Advisor Networks’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$323K	Buy	11,984 +78	+0.7%	+$2.22K	﹤0.01%	2232
2023 Q4	$357K	Buy	+11,906	New	+$263K	﹤0.01%	2120
2021 Q4	–	Sell	-10,095	Closed	-$302K	–	2112
2021 Q3	$302K	Buy	10,095 +3,807	+61%	+$139K	﹤0.01%	1513
2021 Q2	$278K	Buy	6,288 +571	+10%	+$24.8K	﹤0.01%	1545
2021 Q1	$254K	Buy	5,717 +2,013	+54%	+$111K	0.01%	1240
2020 Q4	$203K	Buy	+3,704	New	+$135K	﹤0.01%	1251
2020 Q3	–	Sell	-5,356	Closed	-$112K	–	2612
2020 Q2	$112K	Buy	+5,356	New	+$96.6K	﹤0.01%	1435

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cetera Advisor Networks's RCKT Position: Q1 2024 in Review

Cetera Advisor Networks increased its Rocket Pharmaceuticals (RCKT) stake by 0.66% in Q1 2024, buying an estimated $2.22K and bringing the position to 11,984 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Cetera Advisor Networks first reported a position in RCKT in Q2 2020 and has held it in 7 quarters since. The position peaked at $357K in Q4 2023. 186 funds tracked by Wall St. Rank hold RCKT as of Q1 2024.

Cetera Advisor Networks held 11,984 shares of Rocket Pharmaceuticals worth $323K as of Q1 2024.
Cetera Advisor Networks bought 78 Rocket Pharmaceuticals shares in Q1 2024, an estimated $2.22K.
Rocket Pharmaceuticals made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2232 holding.
Cetera Advisor Networks first reported a position in Rocket Pharmaceuticals in Q2 2020 and has held it in 7 quarters since.
Cetera Advisor Networks's Rocket Pharmaceuticals position peaked at $357K in Q4 2023.
186 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.